PHARMACOLOGICAL DISPOSITION OF 1,4-BIS(2-((2-HYDROXYETHYL) AMINO) ETHYLAMINO)-9,10-ANTHRACENEDIONE DIACETATE IN THE DOGLU K; TI LI LOO.1980; CANCER RES.; USA; DA. 1980; VOL. 40; NO 5; PP. 1427-1430; BIBL. 8 REF.Article

THE PHARMACOLOGIC FATE OF THE ANTITUMOR AGENT 2-AMINO-1,3,4-THIADIAZOLE IN THE DOGLU K; TI LI LOO.1980; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1980; VOL. 4; NO 4; PP. 275-279; BIBL. 7 REF.Article

CLINICAL PHARMACOLOGY OF SYSTEMIC CHEMOTHERAPEUTIC AGENTS IN SKIN NEOPLASMSHALL SW; TI LI LOO.1978; INTERNATION. J. DERMATOL.; USA; DA. 1978; VOL. 17; NO 8; PP. 659-665; BIBL. 24 REF.Article

HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC ANALYSIS OF THE ANTICANCER AGENT METHYLGLYOXAL BIS(GUANYLHYDRAZONE) (MGBG, NSC-32946) IN BIOLOGICAL FLUIDSROSENBLUM MG; TI LI LOO.1980; J. CHROMATOGR.; ISSN 0021-9673; NLD; DA. 1980; VOL. 183; NO 3; PP. 363-366; BIBL. 6 REF.Article

MECHANISM OF ACTION OF 5-(3,3-DIMETHYL-1-TRIAZENO) IMIDAZOLE-4-CARBOXAMIDE IN MAMMALIAN CELLS IN CULTUREGERULATH AH; TI LI LOO.1972; BIOCHEM. PHARMACOL.; G.B.; DA. 1972; VOL. 21; NO 17; PP. 2335-2343; BIBL. 20REF.Serial Issue

Pharmacokinetic studies of mitoxantrone = Pharmacocinétique de la mitoxantroneLU, K; SAVARAJ, N; TI LI LOO et al.Monograph series of the European Organization for Research on Treatment of Cancer. 1983, Vol 12, pp 71-84, issn 0146-0447Article

Inhibition of ribonucleotide reductase by caracemideCOLLEEN MOORE, E; TI LI LOO.Cancer treatment reports. 1984, Vol 68, Num 10, pp 1293-1294, issn 0361-5960Article

Pharmacological disposition of 1,4-dihydroxy-5-8-bis[[2[(2-hydroxyethal)amino] ethyl]amino]-9,10-anthracenedione dihydrochloride in the dogLU, K; NIRAMOL SAVARAJ; TI LI LOO et al.Cancer chemotherapy and pharmacology. 1984, Vol 13, Num 1, pp 63-66, issn 0344-5704Article

COMBINATION CHEMOTHERAPY IN VITRO WITH CISDICHLORODIAMMINEPLATINUM (II).DREWINKO B; GREEN C; TI LI LOO et al.1976; CANCER TREATM. REP.; U.S.A.; DA. 1976; VOL. 60; NO 11; PP. 1619-1625; BIBL. 1 P.Article

CLINICAL PHARMACOLOGY OF INTRAVENOUSLY ADMINISTERED TRIME THO PRIM-SULFAMETHOXAZOLEGROSE WE; BODEY GP; TI LI LOO et al.1979; ANTIMICROB. AGENTS CHEMOTHERAPY; USA; DA. 1979; VOL. 15; NO 3; PP. 447-451; BIBL. 20 REF.Article

SYNTHESIS AND ANTITUMOR ACTIVITY OF HALOGEN-SUBSTITUTED 4-(3,3-DIMETHYL-1-TRIAZENO) QUINOLINES.AI JENG LIN; TI LI LOO.1978; J. MEDICIN. CHEM.; U.S.A.; DA. 1978; VOL. 21; NO 3; PP. 268-272; BIBL. 36 REF.Article

COMPARISON OF THE REVERSED-PHASE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC SEPARATIONS OF FLUOROPYRIMIDINES, PYRIMIDINES, AND PURINESMILLER AA; BENVENUTO JA; TI LI LOO et al.1982; J. CHROMATOGR.; ISSN 0021-9673; NLD; DA. 1982; VOL. 228; PP. 165-176; BIBL. 23 REF.Article

EFFECT OF THYMIDINE ON THE TOXICITY AND ANTITUMOR ACTIVITY OF FTORAFURGROSSIE VB JR; TI LI LOO.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 11-12; PP. 1087-1091; BIBL. 12 REF.Article

IDENTIFICATION OF THE METABOLITES OF AN ANTITUMOR TRICYCLIC NUCLEOSIDE (NSC-154020)SCHWEINSBERG PD; SMITH RG; TI LI LOO et al.1981; BIOCHEM. PHARMACOL.; ISSN 0006-2952; GBR; DA. 1981; VOL. 30; NO 18; PP. 2521-2526; BIBL. 12 REF.Article

COMBINATION CHEMOTHERAPY IN VITRO. III. BCNUDREWINKO B; TI LI LOO; FREIREICH EJ et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 3; PP. 373-375; BIBL. 21 REF.Article

CLINICAL PHARMACOKINETICS OF VINBLASTINE BY CONTINUOUS INTRAVENOUS INFUSION = PHARMACOCINETIQUE CLINIQUE DE LA VINBLASTINE PAR PERFUSION INTRAVEINEUSE CONTINUELU K; HWEE YONGYAP; TI LI LOO et al.1983; CANCER RESEARCH; ISSN 0008-5472; USA; DA. 1983; VOL. 43; NO 3; PP. 1405-1408; ABS. ENG; BIBL. 10 REF.; GRAPHArticle

CELLULAR RESPONSE TO TREATMENT WITH 4-(3-(2-CHLOROETHYL)-3-NITROSOUREIDO)-CIS-CYCLOHEXANECARBOXYLIC ACID, A WATER-SOLUBLE NITROSOUREA DERIVATIVE.DREWINKO B; GREEN C; TI LI LOO et al.1977; CANCER TREATM. REP.; U.S.A.; DA. 1977; VOL. 61; NO 8; PP. 1513-1518; BIBL. 20 REF.Article

Alkylation of DNA by the new anticancer agent 3,6-diaziridinyl-2,5-bis(carboethoxyamino)-1,4-benzoquinone (AZQ) = Alkylation du DNA par le nouvel agent anticancéreux, le 3,6-diaziridinyl-2,5-bis(carboéthoxyamino)-1,4-benzoquinone (AZQ)CHEUNG LAM KING; SIN-KUEN WONG; TI LI LOO et al.European journal of cancer & clinical oncology. 1984, Vol 20, Num 2, pp 261-264, issn 0277-5379Article

CLINICAL PHARMACOKINETICS OF 5-METHYLTETRAHYDROHOMOFOLATE = PHARMACOCINETIQUE CLINIQUE DU 5-METHYLTETRAHYDROHOMOFOLATETI LI LOO; LIU HIUSHI; LU K et al.1983; CANCER RESEARCH; ISSN 0008-5472; USA; DA. 1983; VOL. 43; NO 2; PP. 921-924; ABS. ENG; BIBL. 11 REF.; GRAPH, FIGArticle

PHARMACOLOGY OF MITOXANTRONE IN CANCER PATIENTSNIRAMOL SAVARAJ; LU K; MANUEL V et al.1982; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1982; VOL. 8; NO 1; PP. 113-117; BIBL. 12 REF.Article

COMPARATIVE STRUCTURE-GENOTOXICITY STUDY OF THREE AMINOANTHRAQUINONE DRUGS AND DOXORUBICINAU WW; BUTLER MA; MATNEY TS et al.1981; CANCER RES.; ISSN 0008-5472; USA; DA. 1981; VOL. 41; NO 2; PP. 376-379; BIBL. 13 REF.Article

DISPOSITION AND METABOLISM OF THIOPURINES. III: BETA -2'-DEOXYTHIOGUANOSINE AND 6-THIOGUANINE IN THE DOGTI LI LOO; LU K; BENVENUTO A et al.1981; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1981; VOL. 6; NO 2; PP. 131-136; BIBL. 11 REF.Article

PHARMACOKINETICS OF (¹⁴C) METHYLGLYOXAL-BIS (GUANYL-HYDRAZONE) IN PATIENTS WITH LEUKEMIAROSENBLUM MG; KEATING MJ; BOH SENG YAP et al.1981; CANCER RES.; ISSN 0008-5472; USA; DA. 1981; VOL. 41; NO 5; PP. 1748-1750; BIBL. 25 REF.Article

ACTIONS OF 3-DEAZAGUANINE AND 3-DEAZAGUANOSINE ON VARIANT LINES OF CHINESE HAMSTER OVARY CELLSSAUNDERS PP; LIAN YU CHAO; TI LI LOO et al.1981; BIOCHEM. PHARMACOL.; ISSN 0006-2952; GBR; DA. 1981; VOL. 30; NO 16; PP. 2374-2376; BIBL. 15 REF.Article

COMPARISON OF THE ACTIVITY OF 2'-DEOXYCOFORMYCIN AND ERYTHRO-9-(2-HYDROXY-3-NONYL) ADENINE IN VIVOPLUNKETT W; ALEXANDER L; CHUBB S et al.1979; BIOCHEM. PHARMACOL.; GBR; DA. 1979; VOL. 28; NO 2; PP. 201-206; BIBL. 43 REF.Article